Evidence map›Paper›PMID 39230332›Full record

ArticleEnvironmental health perspectives2024

Impact of Skin Care Products on Phthalates and Phthalate Replacements in Children: the ECHO-FGS.

Michael S Bloom, Juliana M Clark, John L Pearce, Pamela L Ferguson, Roger B Newman, James R Roberts, William A Grobman, Anthony C Sciscione, Daniel W Skupski, Kelly Garcia and 3 more

Erratum issuedAbstract read
In one paragraph

Article in Environmental health perspectives, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Review
  8. Article
  9. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

13 authors.

Michael S BloomDepartment of Global and Community Health, George Mason University, Fairfax, Virginia, USA.ORCID 0000-0002-0028-5494
Juliana M ClarkDepartment of Global and Community Health, George Mason University, Fairfax, Virginia, USA.
John L PearceDepartment of Public Health Sciences, Medical University of South Carolina, Charleston, South Carolina, USA.
Pamela L FergusonDepartment of Public Health Sciences, Medical University of South Carolina, Charleston, South Carolina, USA.
Roger B NewmanDepartment of Obstetrics and Gynecology, Medical University of South Carolina, Charleston, South Carolina, USA.
James R RobertsDepartment of Pediatrics, Medical University of South Carolina, Charleston, South Carolina, USA.
William A GrobmanDepartment of Obstetrics and Gynecology, The Ohio State University Wexner Medical Center, Columbus, Ohio, USA.
Anthony C SciscioneDepartment of Obstetrics and Gynecology, Christiana Care Health System, Newark, Delaware, USA.
Daniel W SkupskiDepartment of Obstetrics and Gynecology, New York-Presbyterian Queens Hospital, Queens, New York, USA.
Kelly GarciaDepartment of Global and Community Health, George Mason University, Fairfax, Virginia, USA.
John E VenaDepartment of Public Health Sciences, Medical University of South Carolina, Charleston, South Carolina, USA.
Kelly J HuntDepartment of Public Health Sciences, Medical University of South Carolina, Charleston, South Carolina, USA.
ECHO-FGS study group

Funding

Statistical Services and Methods Development ResourceU2CES026555 · NIEHS · ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI · PI GENNINGS, CHRIS · 2015 to 2025
$26.4M
Exposome Contributors to Child Health Originating from National Fetal Growth Study (ECCHO-NFGS)UG3OD023316 · OD · MEDICAL UNIVERSITY OF SOUTH CAROLINA · PI HUNT, KELLY J, WAPNER, RONALD · 2016 to 2017
$10.8M
Untargeted Analysis ResourceU2CES026553 · NIEHS · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI MEEKER, JOHN D. · 2015 to 2015
$9.5M
A South Carolina ECHO Pregnancy CohortUH3OD035543 · OD · MEDICAL UNIVERSITY OF SOUTH CAROLINA · PI KELLY J HUNT, ROGER B NEWMAN · 2025 to 2026
$5.0M
A South Carolina ECHO Pregnancy CohortUG3OD035543 · OD · MEDICAL UNIVERSITY OF SOUTH CAROLINA · PI HUNT, KELLY J, NEWMAN, ROGER B · 2023 to 2024
$2.5M
Enhancing the IMHRD cohort to support study of the exposome in autoimmune diseaseR21AR084039 · NIAMS · MEDICAL UNIVERSITY OF SOUTH CAROLINA · PI PEARCE, JOHN LANIER · 2023 to 2025
$607k
NIAMS NIH HHS R21 AR084039NICHD NIH HHS HHSN275200800002CNICHD NIH HHS HHSN275200800002INICHD NIH HHS HHSN275200800003CNICHD NIH HHS HHSN275200800003INICHD NIH HHS HHSN275200800012CNICHD NIH HHS HHSN275200800013CNICHD NIH HHS HHSN275200800014CNICHD NIH HHS HHSN275200800028CNICHD NIH HHS HHSN275201000009CNIEHS NIH HHS U2C ES026553NIEHS NIH HHS U2C ES026555NIH HHS UG3 OD023316NIH HHS UG3 OD035543NIH HHS UH3 OD035543
6 · The paper itself

Abstract

backgroundPhthalates and their replacements have been implicated as developmental toxicants. Young children may be exposed to phthalates/replacements when using skin care products (SCPs).

objectivesOur objective is to assess the associations between use of SCPs and children's urinary phthalate/replacement metabolite concentrations.

methodsChildren (4-8 years old) from the Environmental Influences on Child Health Outcomes-Fetal Growth Study (ECHO-FGS) cohort provided spot urine samples from 2017 to 2019, and mothers were queried about children's SCP use in the past 24 h (

resultsChildren had lotions applied (43.0%) frequently, but "2-in-1" hair-care products (7.5%), sunscreens (5.9%), and oils (4.3%) infrequently. Use of lotions was associated with 1.17-fold [95% confidence interval (CI): 1.00, 1.34] greater mono-benzyl phthalate and oils with 2.86-fold (95% CI: 1.89, 4.31) greater monoethyl phthalate (MEP), 1.43-fold (95% CI: 1.09, 1.90) greater monobutyl phthalate (MBP), and 1.40-fold (95% CI: 1.22, 1.61) greater low-molecular-weight phthalates (LMW). Use of 2-in-1 haircare products was associated with 0.84-fold (95% CI: 0.72, 0.97) and 0.78-fold (95% CI: 0.62, 0.98) lesser mono(3-carboxypropyl) phthalate (MCPP) and MBP, respectively. Child's race/ethnic identity modified the associations of lotions with LMW, oils with MEP and LMW, sunscreen with MCPP, ointments with MEP, and hair conditioner with MCPP. SOM identified four distinct SCP-use exposure scenarios (i.e., profiles) within our population that predicted 1.09-fold (95% CI: 1.03, 1.15) greater mono-carboxy isononyl phthalate, 1.31-fold (95% CI: 0.98, 1.77) greater mono-2-ethyl-5-hydroxyhexyl terephthalate, 1.13-fold (95% CI: 0.99, 1.29) greater monoethylhexyl phthalate, and 1.04-fold (95% CI: 1.00, 1.09) greater diethylhexyl phthalate. DISCUSSION: We found that reported SCP use was associated with urinary phthalate/replacement metabolites in young children. These results may inform policymakers, clinicians, and parents to help limit children's exposure to developmental toxicants. https://doi.org/10.1289/EHP13937.

Indexed as

Phthalic AcidsChildChild, PreschoolCosmeticsEnvironmental ExposureEnvironmental PollutantsFemaleHumansMaleSkin CareCosmeticsEnvironmental Pollutantsphthalic acidPhthalic Acids

Identifiers

PMID39230332
PMCPMC11373421

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.